Are Accelerated Underwriting (AU) programs performing as expected? As mortality experience will (hopefully) be slow to emerge, it is pivotal that we look at alternative methods of monitoring early performance. From random hold outs, to post-issue APS's, and post-issue prescription profiles, explore popular monitoring techniques and lessons learned so far. Focus on confusion matrices that provide an early indication of mortality slippage relative to fluid-based underwriting decisions. Finally, explore statistical methods to determine what constitutes credibility and identify opportunities to think about mortality slippage more robustly.
By attending the session, you will be able to:
- Understand the importance of tracking AU program performance.
- Describe popular methods and pros/cons of each.
- Get a glimpse at aggregated confusion matrices to understand approximate AU slippage across the industry.
- Assign confidence intervals around the actual mortality slippage based on these early AU observations.
TRACK: Spearheading innovation through change, Cultivating future opportunities, Protecting long-term economic progress
Edition